Matthew Korn

Company: Bayer

Job title: Global Medical Lead

Seminars:

Considerations for Designing an Optimal First in Human Radiopharmaceutical Trial 11:45 am

• Considerations on candidate selection when working with a multidisciplinary team • Evolving strategy and lessons learned moving from lab to clinic • FIH study design dynamics about safety, dosimetry and PK/PD from Th227 to Ac225Read more

day: Day One ESC AM

Panel Discussion: Reflecting on the Past Year- Discussing Current Radiopharmaceutical Trends & Assessing Our Progress 8:30 am

Exploring PSMA updates and predictions for the future market of prostate cancer drugs Pricing and reimbursement considerations in a competitive market Discussing key future commercial challenges and opportunities for the field from advances in manufacturing to competitive demand and selection of radioisotopes, with emphasis on actinium-225, lead-212, copper-64Read more

day: Conference Day One

Addressing the Silos to Move Toward an Integrated Approach With Enhanced Trial Design & Execution Across Radiopharmaceutical Research 8:30 am

Radiopharmaceutical development is driven by collaboration between radio pharmacists, nuclear medicine specialists, chemists, bioengineers and more. While the industry is on the brink of expanding their horizons to even more unmet medical needs, there is a clear bottleneck in the blend of expertise required to design and run a radiopharmaceutical trial. Learn perspectives from key…Read more

day: Workshop D